Citation Impact
47 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
2024 Standout
Works of David Tse being referenced
Genomic profiling by cell-free circulating tumor DNA in patients with recurrent adenoid cystic carcinoma (ACC) and the potential activity of selective fibroblast growth factor receptor (FGFR) inhibitors.
2021
Safety and Effects of the Vector for the Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial
2014
Author Peers
| Author | Surgery | Ophthalmology | Oncology | Molecular Biology | PFM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| David Tse | 22 | 25 | 36 | 82 | 45 | 13 | 163 | |
| Kuo-Hsi Cheng | 51 | 4 | 13 | 511 | ||||
| Adam Gates | 8 | 1 | 28 | 608 | 4 | 13 | 1.2k | |
| Kathleen M. Kershaw | 12 | 2 | 47 | 118 | 24 | 5 | 161 | |
| Peter Hoeller | 1 | 14 | 200 | |||||
| Nicholas F. Grigoropoulos | 7 | 73 | 41 | 55 | 13 | 158 |
All Works
Loading papers...